US20160283696A1 - Methods and device arrangement for physical activity thresholds promoting fat and cholesterol metabolism in high risk subjects - Google Patents

Methods and device arrangement for physical activity thresholds promoting fat and cholesterol metabolism in high risk subjects Download PDF

Info

Publication number
US20160283696A1
US20160283696A1 US15/034,185 US201415034185A US2016283696A1 US 20160283696 A1 US20160283696 A1 US 20160283696A1 US 201415034185 A US201415034185 A US 201415034185A US 2016283696 A1 US2016283696 A1 US 2016283696A1
Authority
US
United States
Prior art keywords
acceleration
physical activity
maxima
person
cholesterol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/034,185
Other languages
English (en)
Inventor
Juhani Leppäluoto
Karl-Heinz Herzig
Riikka Ahola
Timo Jämsä
Jari Jokelainen
Sirkka Keinänen-Kiukaanniemi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gleap Health Technologies Oy
SARTORIO OY
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of US20160283696A1 publication Critical patent/US20160283696A1/en
Assigned to SARTORIO OY reassignment SARTORIO OY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AHOLA, RIIKKA, KEINÄNEN-KIUKAANNIEMI, Sirkka, HERZIG, KARL-HEINZ, JÄMSÄ, Timo, JOKELAINEN, JARI, LEPPÄLUOTO, Juhani
Assigned to GLEAP HEALTH TECHNOLOGIES OY reassignment GLEAP HEALTH TECHNOLOGIES OY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SARTORIO OY
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235Details of waveform analysis
    • A61B5/7264Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
    • G06F19/3481
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
    • A61B5/1118Determining activity level
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4866Evaluating metabolism
    • AHUMAN NECESSITIES
    • A63SPORTS; GAMES; AMUSEMENTS
    • A63BAPPARATUS FOR PHYSICAL TRAINING, GYMNASTICS, SWIMMING, CLIMBING, OR FENCING; BALL GAMES; TRAINING EQUIPMENT
    • A63B69/00Training appliances or apparatus for special sports
    • A63B69/0028Training appliances or apparatus for special sports for running, jogging or speed-walking
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/30ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0219Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01PMEASURING LINEAR OR ANGULAR SPEED, ACCELERATION, DECELERATION, OR SHOCK; INDICATING PRESENCE, ABSENCE, OR DIRECTION, OF MOVEMENT
    • G01P15/00Measuring acceleration; Measuring deceleration; Measuring shock, i.e. sudden change of acceleration

Definitions

  • the invention relates to method and device for determining physical activity thresholds to improving sugar, cholesterol and fat metabolism in subjects who have sedentary life style.
  • the use of motion sensors and transduction units to measure physical activity intensity and volume have been presented in U.S.2008/0312560A1, WO02005117703.
  • a method in which physical activity improving cholesterol metabolism in healthy subjects is presented in U.S. 2010/0137107 A1.
  • the invention described here belongs to the medical discipline and includes the determination of physical activity thresholds that can be used for preventing risks for metabolic diseases such as diabetes and cardiovascular disease by reducing blood cholesterol, triglycerides and visceral fat mass.
  • the earlier invention purposed for healthy subjects related to physical activity reducing blood cholesterol (U.S. 2010/0137107 A1) is not suitable to subjects who have risks of diabetes and/or cardiovascular diseases, as they are not capable to perform prescribed physical activity previously shown to reduce blood cholesterol in healthy subjects (Herzig et al. 2014 Int J Obesity38:1089).
  • Calcification of blood vessels, high blood sugar, cholesterol and triglycerides are risk factors for diabetes and cardiovascular diseases. These risk factors can be reduced by increased physical activity and weight reduction programs. Increased exercise will lead to decreases in blood LDL-cholesterol and increases HDL-cholesterol (tannescu et a. 2002 JAMA, 288,4994, Kraus et al. 2002, NEJM 347, 1483) all reducing risks of cardiovascular diseases. In a similar way increased weekly exercise and weight reduction programs prevented developing of the type 2 diabetes in 60% of patients (Tuomilehto et al. 2002,NEJM 304.1343, Knowler et al. 2002, NEJM 346:393).
  • Fat tissues especially those around the internal organs are body's energy sources and are released to blood circulation during exercises. It has been shown that during exercises fat from the internal organs is first mobilized and starts the reduction of body weight (O'Leary et al. 2009, J Appl Physiol 100,1958).
  • the invention described here manages physical activity thresholds reducing blood cholesterol, triglycerides and visceral fat in overweight subjects with metabolic disorders. These subjects are not able to reach physical activity thresholds presented in the patent (U.S. 20107137107), and therefore they need their own physical activity thresholds.
  • the patents U.S. 2008/0312560 A1 and U.S. 2010/137107 A1 and the one described here belong to the same patents family, in which determining of physical activity thresholds are novel and differ from the previously known techniques
  • Accelerometers (patents U.S. 2010191155 A1, EP 0700661 A2, U.S. 2009171614 A1, EP 2210557 A1 and U.S. 2001049470 A1) and a heart rate monitor (U.S. 20110213) have been previously used for measuring energy expenditure of physical activity or following body weight and nutrient intake in healthy subjects and heart rate monitor for protein consumption and recovery in athletes. It should be noted that all the above mentioned methods measuring energy expenditure are useless for establishing threshold levels improving health. For instance in a previous study we demonstrated that walking 12982 daily steps at the acceleration range 0.3-1.0 g had no effect on blood cholesterol, whereas 1062 daily steps at the acceleration range 1.1-2.4 g reduced blood cholesterol by 15% (Vainionischen et al.
  • Our invention has many advantages. It makes it possible to determine for the first time the volume and intensity of the physical activity threshold reducing disease risks in subjects, who are sedentary, have overweight and suffer from metabolic disorders. These subjects cover approximately 50% of the population and previously there have not been any physical activity recommendations for them.
  • the accelerometer described in the intervention can be easily used continuously making it possible to register all types of physical activity including habitual activities. This will make it easy to meet our novel physical activity recommendations. From the point of preventive medicine walking is also the best form of physical activity. It activates the biggest muscles in the body and its energy expenditure can be accurately measured by accelerometers recording number of steps and step induced accelerations or walking speeds. Maintaining walking ability protects also from falling accidents and hospitalization.
  • the results presented in FIG. 1A and 1B are derived from 68 subjects carrying accelerometer for 3 months.
  • the subjects were overweight men and women aged 30-70 years and had abnormal blood sugar.
  • One half of the subjects participated in supervised exercise weekly and the other half continued their normal life style.
  • the subjects carried accelerometers during wake-full time on their waist.
  • the acceleration values their daily numbers were continuously registered.
  • Blood samples were taken at the beginning and end of the trial to measure blood sugar, insulin, cholesterol, LDL-cholesterol and triglycerides.
  • the amount of the visceral fat was measured by a bio-impedance method.
  • the distribution of the accelerations during 3 months showed that exercises increased significantly number of steps or impacts in the acceleration classes 0.3-0.7 g, corresponding typically to slow walking 2-3 km/h.
  • the steps in the acceleration class 0.3-0.7 were divided by their magnitudes to quartiles. Cholesterol and fat concentrations between each quartile were analyzed. The results showed ( FIG. 1A and 1B ) that total cholesterol, LDL-cholesterol, triglycerides, and visceral fat in the fourth quartile (over 6520 daily steps) were significantly lower than in the other quartiles. 6520 daily steps is the threshold for physical activity, the exceeding of which reduced total cholesterol by 0.6 mmol/l, LDL-cholesterol 0.7 mmol/l, triglycerides 0.4 mmol/l and the area of visceral fat by 12%.
  • the invention described herein does essentially differ from the previously known methods by which exercises have been used for prevention of risk factors of diabetes and cardiovascular diseases. Physicians have generally been aware about the beneficial effects of regular exercise, but the volume, intensity and duration of the exercises have been unknown. It was novel and unexpected in our invention that in sedentary subjects physical activity of very low intensity (accelerations 0.3-0.7 g) reduced concentrations of the major risk factors of diabetes and cardiovascular diseases. Our invention is also different form other patents and recommendations, since those do not take low intensity exercise into account.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Physiology (AREA)
  • Artificial Intelligence (AREA)
  • Dentistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Signal Processing (AREA)
  • Epidemiology (AREA)
  • Fuzzy Systems (AREA)
  • Mathematical Physics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Psychiatry (AREA)
  • Primary Health Care (AREA)
  • Evolutionary Computation (AREA)
  • Obesity (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
US15/034,185 2013-11-04 2014-10-31 Methods and device arrangement for physical activity thresholds promoting fat and cholesterol metabolism in high risk subjects Abandoned US20160283696A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20130323 2013-11-04
FI20130323A FI20130323A (sv) 2013-11-04 2013-11-04 Förfarande för mätning av ett tröskelvärde för motion som främjar fett- och kolesterolmetabolism och minskar mängden fettvävnad hos personer med övervikt eller förhöjd risk för hjärtsjukdom och diabetes
PCT/FI2014/000031 WO2015063366A1 (en) 2013-11-04 2014-10-31 Methods and device arrangement for physical activity thresholds promoting fat and cholesterol metabolism in high risk subjects

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/FI2014/000031 A-371-Of-International WO2015063366A1 (en) 2013-11-04 2014-10-31 Methods and device arrangement for physical activity thresholds promoting fat and cholesterol metabolism in high risk subjects

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US16/438,506 Continuation-In-Part US20190290191A1 (en) 2013-11-04 2019-06-12 Low impact physical activities for reducing risk of cholesterol and fat metabolism disorders in overweight people

Publications (1)

Publication Number Publication Date
US20160283696A1 true US20160283696A1 (en) 2016-09-29

Family

ID=53003410

Family Applications (1)

Application Number Title Priority Date Filing Date
US15/034,185 Abandoned US20160283696A1 (en) 2013-11-04 2014-10-31 Methods and device arrangement for physical activity thresholds promoting fat and cholesterol metabolism in high risk subjects

Country Status (6)

Country Link
US (1) US20160283696A1 (sv)
EP (1) EP3065639A4 (sv)
JP (1) JP6777543B2 (sv)
CN (1) CN106255458A (sv)
FI (1) FI20130323A (sv)
WO (1) WO2015063366A1 (sv)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019043292A1 (en) * 2017-08-29 2019-03-07 Gleap Health Technologies Oy METHODS AND ARRANGEMENT OF THRESHOLD DEVICE OF PHYSICAL ACTIVITY REDUCING THE RISKS OF DIABETES, CARDIOVASCULAR DISEASES, INFLAMMATIONS, DEMENTIA, CANCERS AND MORTALITY IN SEDENTARY SUBJECTS
WO2020111787A1 (en) * 2018-11-29 2020-06-04 Samsung Electronics Co., Ltd. Method for providing recommendations for maintaining a healthy lifestyle basing on daily activity parameters of user, automatically tracked in real time, and corresponding system

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115191961B (zh) * 2021-04-09 2024-08-23 广东小天才科技有限公司 心肺健康检测方法及装置、可穿戴设备、存储介质

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2229224T3 (es) 1994-09-07 2005-04-16 Omron Healthcare Co., Ltd. Dispositivo medidor de una cantidad de ejercicio, capaz de presentar la cantidad de ejercicio que todavia ha de realizarse.
JP3027346B2 (ja) * 1997-05-21 2000-04-04 株式会社スズケン 運動レベル経時記憶装置
US6513532B2 (en) 2000-01-19 2003-02-04 Healthetech, Inc. Diet and activity-monitoring device
FI118951B (sv) 2004-06-04 2008-05-30 Newtest Oy Givarenhet, anordningsarrangemang och förfarande som utnyttjar anordningsarrangemanget för att bilda och visa en bedömning av benmassautveckling
JP4826191B2 (ja) * 2005-09-27 2011-11-30 パナソニック電工株式会社 活動量計
JP4830765B2 (ja) * 2006-09-29 2011-12-07 パナソニック電工株式会社 活動量計測システム
FI20061097A0 (sv) * 2006-12-11 2006-12-11 Timo Jaakko Jaemsae Förfarande för att mäta motion som befrämjar kolesterolmetabolism
JP2008154878A (ja) * 2006-12-25 2008-07-10 Matsushita Electric Works Ltd 階段昇降判別装置及び活動量計
JP2008246179A (ja) * 2007-03-30 2008-10-16 Matsushita Electric Works Ltd 活動量計
JP2009022440A (ja) * 2007-07-18 2009-02-05 Seiko Instruments Inc ゲームシステム及び運動量測定装置
JP5202933B2 (ja) * 2007-11-30 2013-06-05 株式会社タニタ 体動検出装置
US7676332B2 (en) 2007-12-27 2010-03-09 Kersh Risk Management, Inc. System and method for processing raw activity energy expenditure data
US9370691B2 (en) * 2008-03-27 2016-06-21 Polar Electro Oy Apparatus for metabolic training load, mechanical stimulus, and recovery time calculation
EP2210557A1 (en) 2009-01-21 2010-07-28 Koninklijke Philips Electronics N.V. Determining energy expenditure of a user
KR20100087551A (ko) * 2009-01-28 2010-08-05 한국과학기술연구원 사용자의 행동 분류에 따른 칼로리 균형 계산 장치
JP5617299B2 (ja) * 2010-03-25 2014-11-05 オムロンヘルスケア株式会社 活動量計、制御プログラムおよび活動種類特定方法
US20150324541A1 (en) * 2011-11-28 2015-11-12 Koninklijke Philips N.V. Health monitoring system for calculating a total risk score
CN103027696B (zh) * 2012-12-06 2016-01-06 可瑞尔科技(扬州)有限公司 人体运动能量消耗仪

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019043292A1 (en) * 2017-08-29 2019-03-07 Gleap Health Technologies Oy METHODS AND ARRANGEMENT OF THRESHOLD DEVICE OF PHYSICAL ACTIVITY REDUCING THE RISKS OF DIABETES, CARDIOVASCULAR DISEASES, INFLAMMATIONS, DEMENTIA, CANCERS AND MORTALITY IN SEDENTARY SUBJECTS
JP2020531236A (ja) * 2017-08-29 2020-11-05 グリープ ヘルス テクノロジーズ オーイー 座りがちな対象の糖尿病、心血管疾患、炎症、認知症、がん、及び死亡率のリスクを軽減する身体活動の閾値に関する方法及び装置の手配
JP7336061B2 (ja) 2017-08-29 2023-08-31 グリープ ヘルス テクノロジーズ オーイー 座りがちな対象の糖尿病、心血管疾患、炎症、認知症、がん、及び死亡率のリスクを軽減する身体活動の閾値に関する方法及び装置の手配
US11804290B2 (en) 2017-08-29 2023-10-31 Gleap Health Technologies Oy Methods and device arrangement for physical activity thresholds reducing risks of diabetes, cardiovascular diseases, inflammations, dementia, cancers and mortality in sedentary subjects
WO2020111787A1 (en) * 2018-11-29 2020-06-04 Samsung Electronics Co., Ltd. Method for providing recommendations for maintaining a healthy lifestyle basing on daily activity parameters of user, automatically tracked in real time, and corresponding system

Also Published As

Publication number Publication date
FI20130323A (sv) 2015-05-05
JP2016535657A (ja) 2016-11-17
EP3065639A1 (en) 2016-09-14
JP6777543B2 (ja) 2020-10-28
WO2015063366A8 (en) 2015-09-24
WO2015063366A1 (en) 2015-05-07
CN106255458A (zh) 2016-12-21
EP3065639A4 (en) 2017-08-02

Similar Documents

Publication Publication Date Title
Hottenrott et al. Effects of high intensity training and continuous endurance training on aerobic capacity and body composition in recreationally active runners
Uusitalo Overtraining: making a difficult diagnosis and implementing targeted treatment
Lorino et al. The effects of caffeine on athletic agility
Lan et al. The exercise intensity of tai chi chuan
Dunn-Lewis et al. The effects of a customized over-the-counter mouth guard on neuromuscular force and power production in trained men and women
Dolan et al. The impact of making weight on physiological and cognitive processes in elite jockeys
US20160283696A1 (en) Methods and device arrangement for physical activity thresholds promoting fat and cholesterol metabolism in high risk subjects
Yanaoka et al. A 1-minute Re-warm up at high-intensity improves sprint performance during the Loughborough intermittent shuttle test
Driver et al. Objective assessment of activity in inpatients with traumatic brain injury: initial findings
Patel et al. A study on the effect of Yoga and diet-control on Body mass index and cholesterol level of the Obese Youth
Das et al. The plausible effects of wearing face masks on sports performance–A scoping review
US11804290B2 (en) Methods and device arrangement for physical activity thresholds reducing risks of diabetes, cardiovascular diseases, inflammations, dementia, cancers and mortality in sedentary subjects
US20190290191A1 (en) Low impact physical activities for reducing risk of cholesterol and fat metabolism disorders in overweight people
Tiwari et al. Outcome of breathing exercise (pranayam) on spirometric parameters in type 2 diabetic individuals: a clinical study
Fagan Exploring the Role of Biofeedback in Physiological Monitoring of Alcohol and Caffeine Consumption in Collegiate Softball Athletes
Liang et al. Respiratory patterns and physical fitness in healthy adults: a cross-sectional study
Mochizuki et al. Evaluation of exercise programs at a fitness club in female exercise beginners using anti-aging medical indicators
Hoffmann et al. Starting in your mental pole position: Hypnosis helps elite Downhill Mountainbike athletes to reach their optimal racing mindset
JP2020531236A5 (sv)
Brewer Non-invasive load monitoring in female Division 1 collegiate gymnastics
Saravanan Comparative analysis of body fat among college level footballers from different parts of India
Siervo et al. Validity of some prediction equations to assess resting energy expenditure (REE) in 29 elderly obese subjects (> 60 years)
Vakili et al. The Effect of Combined Training and Vitamin D Supplementation on some Indicators of Liver Damage, Performance and Depression in Women Addicted to Methamphetamine and Heroin.
Aziakpono et al. Alcohol and Glucose D consumption decreases grip muscle strengths in graded doses
Franà et al. RELATIONSHIP OF CARDIORESPIRATORY FITNESS WITH CARDIOVASCULAR RISK FACTORS, PERCEIVED STRESS AND RESPIRATORY FUNCTION IN STREET RUNNING ATHLETES

Legal Events

Date Code Title Description
AS Assignment

Owner name: SARTORIO OY, FINLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LEPPAELUOTO, JUHANI;HERZIG, KARL-HEINZ;AHOLA, RIIKKA;AND OTHERS;SIGNING DATES FROM 20180413 TO 20180417;REEL/FRAME:045816/0628

Owner name: GLEAP HEALTH TECHNOLOGIES OY, FINLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SARTORIO OY;REEL/FRAME:045816/0644

Effective date: 20180417

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION